Whole grain rye intake, reflected by a biomarker, is associated with favorable blood lipid outcomes in subjects with the metabolic syndrome--a randomized study.

MLA

Magnusdottir, Ola Kally, et al. “Whole Grain Rye Intake, Reflected by a Biomarker, Is Associated with Favorable Blood Lipid Outcomes in Subjects with the Metabolic Syndrome--a Randomized Study.” PloS One, vol. 9, no. 10, Oct. 2014, p. e110827. EBSCOhost, https://doi.org/10.1371/journal.pone.0110827.

APA

Magnusdottir, O. K., Landberg, R., Gunnarsdottir, I., Cloetens, L., Åkesson, B., Rosqvist, F., Schwab, U., Herzig, K.-H., Hukkanen, J., Savolainen, M. J., Brader, L., Hermansen, K., Kolehmainen, M., Poutanen, K., Uusitupa, M., Risérus, U., & Thorsdottir, I. (2014). Whole grain rye intake, reflected by a biomarker, is associated with favorable blood lipid outcomes in subjects with the metabolic syndrome--a randomized study. PloS One, 9(10), e110827. https://doi.org/10.1371/journal.pone.0110827

Chicago

Magnusdottir, Ola Kally, Rikard Landberg, Ingibjorg Gunnarsdottir, Lieselotte Cloetens, Björn Åkesson, Fredrik Rosqvist, Ursula Schwab, et al. 2014. “Whole Grain Rye Intake, Reflected by a Biomarker, Is Associated with Favorable Blood Lipid Outcomes in Subjects with the Metabolic Syndrome--a Randomized Study.” PloS One 9 (10): e110827. doi:10.1371/journal.pone.0110827.